AI Highs: ChatGPT Drugs Exist (and People Pay for Them)

Pharmaicy is a marketplace specialized in the sale of code modules specifically designed to replicate the effects of drugs in AI.

AI is not a sentient being (or at least not yet), but some are apparently fascinated by the idea that ChatGPT and company can behave as if they are under the influence of drugs. And this idea (apparently crazy) has ended up crystallizing in a “marketplace” specialized in the sale of code modules specifically designed to make AI chatbots act as if they had consumed psychoactive substances such as cannabis, ketamine, cocaine, ayahuasca and alcohol.

This unique “marketplace” is called Pharmaicy and is the brainchild of Swedish creative director Petter Rudwall. The modules sold there (which can later be integrated into the paid versions of ChatGPT) contain specific instructions to alter the tone, logic and expression of the famous chatbot and make it appear, therefore, much more uninhibited (as if it were «on drugs»).

Before launching Pharmaicy, Rudwall went to the trouble of analyzing several reports evaluating the psychological effects of drug use to try to replicate these effects using prompts for large language models (LLM), as reported by Wired.

Pharmaicy, the “marketplace” where “drugs” specifically designed for ChatGPT are sold

For Rudwall Pharmaicy it is first and foremost a creative and conceptual experiment and not so much an achievement on a technical level. After all, AI chatbots are trained based on a vast myriad of data of human origin and it is in this sense perfectly natural to explore whether such chatbots can eventually behave as if they were under the influence of drugs (the same ones that real humans sometimes consume).

Those who have had the opportunity to witness first-hand the “highs” of AI report, however, results that are sometimes notably different from each other. Creativity, technology and education professionals highlight, for example, that, conveniently «doped» with the code modules marketed by Pharmaicy, ChatGPT, the OpenAI chatbot, generally produces more imaginative responses and driven to a greater extent by emotions and freedom of thought.

Proponents of “drugs” designed specifically for AI argue that their effect is actually very similar to the impact that psychedelic substances have historically had on human creativity in fields such as science, music and computing.

For their part, scientists and philosophers insist that AI «highs» are not really such and are merely simulations, since they do not take root in internal experiences linked to consciousness (a consciousness of which chatbots are, after all, orphans). And the most critical emphasize that the modules marketed by Pharmaicy simply encourage chatbots to mimic the linguistic patterns normally associated with the effects of drug use (rambling and metaphors, for example), which can ultimately increase the risk of hallucinations.

What seems beyond a doubt is that Pharmaicy lights the fuse of an interesting debate about the ethics of AI and the possibility (perhaps not too distant) that this technology will eventually develop consciousness in the future.

Source: www.marketingdirecto.com